Determinants of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients

被引:0
|
作者
Walraven, Iris [1 ]
Ten Berge, M. [2 ]
Damhuis, Ronald [3 ]
Tissing-Tan, C. [4 ]
Troost, E. [5 ]
Reymen, B. [5 ]
Widder, J. [6 ]
Koppe, F. [7 ]
Van Der Wel, A. [8 ]
Vonk, E. [9 ]
Coremans, I. [10 ]
Bussink, J. [11 ]
De Jaeger, K. [12 ]
Van Zyp, N. Van Der Voort [13 ]
El Sharouni, Sherif [14 ]
Knol, H. [15 ]
Woutersen, D. [16 ]
Belderbos, Jose [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Comprehens Canc Ctr Netherlands, Rotterdam, Netherlands
[4] Inst Radiat Oncol Arnhem, Arnhem, Netherlands
[5] Maastricht Univ, Med Ctr, Dept Radiat Oncol, Maastro Clin, NL-6200 MD Maastricht, Netherlands
[6] Univ Med Ctr Groningen, Dept Radiat Oncol, NL-9713 AV Groningen, Netherlands
[7] Verbeeten Inst, Dept Radiat Oncol, Tilburg, Netherlands
[8] Radiotherapy Inst Friesland, Dept Radiat Oncol, Leeuwarden, Netherlands
[9] Radiotherapeut Inst Stedendriehoek & Omstreken Ri, Dept Radiat Oncol, Deventer, Netherlands
[10] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
[11] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands
[12] Catharina Hosp, Dept Radiat Oncol, Eindhoven, Netherlands
[13] Med Ctr Haaglanden, Dept Radiat Oncol, The Hague, Netherlands
[14] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands
[15] Med Ctr Alkmaar, Dept Radiat Oncol, Alkmaar, Netherlands
[16] Med Spectrum Twente, Dept Radiat Oncol, Enschede, Netherlands
关键词
sequential chemoradiotherapy; non-small cell lung cancer; concurrent chemoradiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-051
引用
收藏
页码:S539 / S539
页数:1
相关论文
共 50 条
  • [31] PET for Prognostic Assessment in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Yilmaz, Ufuk
    Asuk, Zehra
    Koparal, Hakan
    Ozbilek, Engin
    Korkmaz, Esra
    Yalcin, Burcu
    Yilmaz, Hasan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S690 - S690
  • [32] Surgery versus concurrent chemoradiotherapy for stage III non-small cell lung cancer: a retrospective study with propensity score matching
    Shigenobu, Takao
    Taniguchi, Yuri
    Suzuki, Takahiro
    Tabuchi, Yuya
    Sato, Mizuki
    Odagiri, Kazumasa
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Okamoto, Hiroaki
    Yoshizu, Akira
    BMC CANCER, 2025, 25 (01)
  • [33] A retrospective analysis of lymphopenia rates during and after sequential and concurrent radical chemoradiotherapy for patients with stage III non-small cell lung cancer (NSCLC)
    Westley, R.
    Philipps, L.
    Lock, I.
    Ahmed, M.
    Mcdonald, F.
    LUNG CANCER, 2019, 127 : S80 - S80
  • [34] SIMULTANEOUS CHEMORADIOTHERAPY VERSUS SEQUENTIAL IN INOPERABLE NON-SMALL CELL LUNG CANCER
    Ragulin, Yury
    Mardynsky, Yury
    Zolotkov, Alexey
    Gulidov, Igor
    Ivanova, Irina
    Medvedev, Victor
    Gogolin, Danil
    Kursova, Larisa
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1573 - S1574
  • [35] Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer
    Robert MacRae
    Hak Choy
    Current Oncology Reports, 2003, 5 (4) : 313 - 317
  • [36] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [37] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [38] Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer
    Yamaguchi, Masafumi
    Toyokawa, Gouji
    Ohba, Taro
    Sasaki, Tomonari
    Kometani, Takuro
    Hamatake, Motoharu
    Hirai, Fumihiko
    Taguchi, Kenichi
    Yamanaka, Takeharu
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Sugio, Kenji
    Ichinose, Yukito
    ANNALS OF THORACIC SURGERY, 2013, 96 (05): : 1783 - 1789
  • [39] How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?
    Bayman, Neil
    Blackhall, Fiona
    McCloskey, Paula
    Taylor, Paul
    Faivre-Finn, Corinne
    LUNG CANCER, 2014, 83 (02) : 117 - 125
  • [40] The impact of right ventricular function on prognosis in patients with stage III non-small cell lung cancer after concurrent chemoradiotherapy
    Lu Chen
    Jingjuan Huang
    Weihua Wu
    Shengjun Ta
    Xiaoyi Xie
    The International Journal of Cardiovascular Imaging, 2019, 35 : 1009 - 1017